Nanjing Jimai Biotechnology

Nanjing Jimai Biotechnology is a specialized biotechnology company focused on DNA-encoded library (DEL) technology for early-stage drug discovery. Based in Nanjing, China, the company provides high-throughput screening services and customized chemical library synthesis to help pharmaceutical and biotech partners identify novel small molecule leads. Their platform integrates advanced synthetic chemistry with molecular biology to screen billions of compounds against diverse biological targets efficiently. Jimai Bio's services aim to significantly reduce the time and cost associated with traditional high-throughput screening methods. The company offers a full suite of services from library design and synthesis to selection and hit validation, supporting the development of innovative therapies across various therapeutic areas.